<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="result">
            <roleset id="result.01" name="" wordnet="2">
                <roles>
                    <role n="0" descr="Theme, prior condition &#x0A;" />
                    <role n="1" descr="Goal, end condition&#x0A;" />
                </roles>
                <example src="PERMUTATE" no="0">
                    <text>Change can cause heat instability and affect CdNA II DNA expression of isoform II in COS7 cells resulting in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>Change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 cells results in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>Change can cause heat instability and affect a new mutation to codon 210 resulting in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>Change can cause heat instability and affect exon 13 jump in s1031 animals resulting in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>Change can cause heat instability and affect float in ras-dependent signaling results in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>Change can cause heat instability and affect fluctuation in ras-dependent signaling resulting in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>Change can cause heat instability and affect fluctuation in ras-dependent signaling resulting in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>Expression of cDNA isoform II DNA in COS7 cells is capable of result rise to a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>Expression of cDNA isoform II DNA in COS7 has finally resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>Expression of cDNA isoform II DNA in COS7, as predicted, may have resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>Expression of cDNA isoform II DNA in COS7, as we have predicted, is likely to resulting in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells, as we have predicted, may resulting in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>Expression of the cD DNA of isoform II in COS7 cells finally resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>Expression of the cdNA II DNA from isoform II in COS7, as we have predicted, will result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that exon 13 jumping in animals s1031 had the ability to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>It has also been reported that a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity resulted from fluctuation in signaling depending on the ras.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>The a new mutation in codon 210, as predicted, has resulted in the replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>The alteration can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 which is able to finally result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>The alteration can cause thermal instability and affect Expression of the cdNA II DNA from isoform II in COS7, which ended up resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>The alteration can cause thermal instability and affect alternative mixed subdomains being observed to result in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>The alteration can cause thermal instability and affect differential spacing being observed to finally result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>The alteration can cause thermal instability and affect failure to use the normal donor site of the intron 12 ear being observed to result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>The alteration can cause thermal instability and affect fluctuation in signaling depending on the ras after having resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>The alteration can cause thermal instability and affect glow in signaling depending on the ras which is observed to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>The alteration can cause thermal instability and affect glow-dependent signaling fluctuation after having resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>The alteration can cause thermal instability and affect reduction of signaling as a function of ras which has proven to result finally in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity .</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>The alteration can result thermal instability and affect expression of cADNA DNA isoform II in COS7 cells which has finally been shown to be a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>The alteration can result thermal instability and affect not to use the normal donor site of the intron 12 ear which is capable of giving rise to a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>The alteration may cause thermal instability and affect Expression of cdNA II DNA of isoform II in COS7 cells which resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>The alteration may cause thermal instability and affect alternative mixed subdomains, which may eventually result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>The alteration may cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 which has been demonstrated to result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on the ras which may result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>The alteration may cause thermal instability and affect multiple alternate subdomains which has been demonstrated to result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>The alteration may cause thermal instability and affect the net charge of the variant subunit, which may ultimately resulted in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>The alternative mixed subdomains has the ability to result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>The change can cause heat instability and affect CdNA II DNA expression of isoform II in COS7 cells which has been shown to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>The change can cause heat instability and affect Exon 13 jumping in s1031 animals by finally being able to result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which has finally resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>The change can cause heat instability and affect a new mutation to codon 210 which will eventually result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation which will eventually result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>The change can cause heat instability and affect expression of the DNA-cDNA ISOform II DNA in COS7 cells which has been shown to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which can result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which eventually resulted in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on ras which has finally resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on the ras that may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on the ras which will eventually result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>The change can cause heat instability and affect liquid charge of varying subunits which can eventually result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>The change can cause heat instability and affect liquid load of the variant subunit which may eventually have resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>The change can cause heat instability and affect liquid load of variant subunit which can eventually result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>The change can cause heat instability and affect liquid load of variant subunit which resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>The change can cause heat instability and affect missing to use the normal donor site of the ear 12 intron which can result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>The change can cause heat instability and affect multiple alternative subdomains which has resulted in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>The change can cause heat instability and affect the net charge of the varying subunit which has finally resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>The change can cause heat instability and affect the net load of the variant subunit which can result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>The change can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 that is observed to finally result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>The change can cause thermal instability and affect fluctuation in ras-dependent signaling and is shown to finally result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>The change can cause thermal instability and affect grid-dependent fluctuation in signaling that is observed to finally result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>The change can cause thermal instability and affect multiple alternate subdomains and is shown to ultimately result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>The change can cause thermal instability and affect some alternative subdomains and is shown to finally result in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>The change can cause thermal instability and affect some alternative subdomains and is shown to finally result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>The change can cause thermal instability and affect some alternative subdomains and is shown to ultimately result in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed alternative mixed subdomains that has the ability to result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed glow-dependent signaling fluctuation that has the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed some alternative subdomains that has the ability to result in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of isoform II cDNA in COS7 cells that resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 and was able to result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon 2 exhaustion (139 nt) and alternative transcriptional start and was able to result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon coupling 139 nt that has the ability to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential slicing that may have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that has the ability to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that is able to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that may result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed glow in signalling depending on the ras that may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed liquid load of the variable subunit that may have resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed missing to use the normal donor site of the ear 12 intron that is able to result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed not to use the normal donor site of the intron 12 ear that may have resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed CdNA II DNA expression of isoform II in COS7 cells that could resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of the cD DNA of isoform II in COS7 cells results in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of the cdNA II DNA from isoform II in COS7 results in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative spacer of a single transcription results in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed expression of the DNA-cDNA ISOform II in COS7 cells that could resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed liquid load of the variable subunit that could resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that expression of cDNA ISOform II DNA in COS7 could result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that not to use the normal donor site of the intron 12 ear could result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of cdNA II DNA of isoform II in COS7 cells and may result rise to a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of cdNA II DNA of isoform II in COS7 cells that results in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation to codon 210 with ability to entirely result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative spacer of a single transcription after having resulted difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes differentiated xis that resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes differentiated xis that results in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling resulted in the complete a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling that are result as entirely a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes glow-dependent signaling fluctuation that resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes missing to use the normal donor site of the ear 12 intron and may result rise to a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduction of signaling as a function of ras that resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes some alternative subdomains with ability to result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes expression of cDNA ISOform II DNA in COS7 that has the ability to completely result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes DNA II expression of Isoform II DNA in COS7 that can result entirely in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a new mutation in codon 210 and is observed to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a new mutation in codon 210 that will result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes fluctuation in signaling depending on the ras and is observed to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes missing to use the normal donor site of the ear 12 intron and is observed to result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes fluctuation in signaling depending on the ras that resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes glow in signalling depending on the ras that has the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a new mutation to codon 210 that may have resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes differential slicing that will result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>The liquid load of the variant subunit and alternative transcriptional initiation, as result in our study, are capable of giving rise to fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>The research shows replace isoleucine with valine resulting from a new mutation in codon 210.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>The sequence analysis of the HDIbeta gene indicates that an electrophoretic subunit of fast-type LDH-B subunits has the ability to result from liquid charge of varying subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>We also report a product of 543 bp that may have resulted from exon 13 juar in s1031 animals.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>We also report the a marked increase in the activity of acetylhydralase of PAF with the capability to result from Expression of isoform II cDNA in COS7 cells.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>a marked increase in the acetylhydrase activity of PAF was able to result from Expression of cdNA II DNA of isoform II in COS7 cells.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>a marked increase in the activity of acetylhydroxylase PAF has the ability to result from expression of the DNA-cDNA ISOform II in COS7 cells.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>a new mutation in codon 210 will finally result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>a new mutation in codon 210, as we have predicted, may have resulted in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>a new mutation to codon 210 can result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start may have resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>alternative exon coupling 139 nt, as predicted, resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>alternative mixed subdomains may ultimately resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>alternative mixed subdomains, as we have predicted, may resulting in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>alternative spacer of a single transcription cells has resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>alternative spacer of a single transcription may ultimately result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>differential spacing may ultimately resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>exon 13 jump in s1031 animals, as predicted, will result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>exon 13 jumping in animals s1031 resulted in a product of 543 bp .</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>expression of cADNA DNA isoform II in COS7 cells may eventually result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>expression of cADNA DNA isoform II in COS7 cells may result in a marked increase in acetylhydratelase PAF activity .</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>expression of cDNA ISOform II DNA in COS7 can result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>expression of cDNA ISOform II DNA in COS7 may result in a marked increase in acetylhydrolase PAF activity .</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>expression of cDNA ISOform II DNA in COS7 will result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>expression of cDNA ISOform II DNA in COS7, as predicted, may have resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>failure to use the normal donor site of the intron 12 ear will result in a variant .</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>fluctuation in ras-dependent signaling eventually resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>fluctuation in ras-dependent signaling has finally resulted in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>fluctuation in ras-dependent signaling, as we have predicted, is likely to resulting in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>fluctuation in signaling depending on ras is likely to resulting in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>fluctuation in signaling depending on ras may result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>fluctuation in signaling depending on ras, as we have predicted, may resulting in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>glow in signalling depending on the ras, as we have predicted, will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>liquid charge of varying subunits cells has the ability to ultimately result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>liquid charge of varying subunits is shown to ultimately result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>liquid charge of varying subunits may eventually result in an electrophoretic subunit of fast-type LDH-B subunits</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>multiple alternate subdomains will eventually result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>multiple alternative subdomains, as we have result, is able to give rise to superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>not to use the normal donor site of the coupling of intron 12, as predicted, will result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>not to use the normal donor site of the intron 12 ear cells can result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>not to use the normal donor site of the intron 12 ear may have resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>reduction of signaling as a function of ras, as we have predicted, may have resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>super-repetitor was able to result from some alternative subdomains.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>the net charge of the variant subunit can ultimately resulted in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="150">
                    <text>the net charge of the variant subunit has finally resulted in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="151">
                    <text>the net charge of the variant subunit is shown to ultimately result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="152">
                    <text>the net charge of the variant subunit may ultimately result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="153">
                    <text>the net charge of the variant subunit resulted in an electrophoretic subunit variant of the fast type LDH-B .</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="154">
                    <text>the net load of the variant subunit has the ability to eventually result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="155">
                    <text>the net load of the variant subunit is likely to resulting in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="156">
                    <text>the net load of the variant subunit may result in a variant electrophoretic subunit LDH-B .</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling cells may have resulted in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling is shown to ultimately result in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>Change can cause heat instability and affect failure to use the normal donor site of splice of intron 12 results in a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>Change can cause heat instability and affect failure to use the normal site of the intron 12 splice donor resulting in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>Decrease Signor of the EGL-15 is likely to resulting in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>Diminutive EGL-15 signal may have resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>It has also been reported that existence of NF-YA isoforms resulted from differential encryption.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>It has also been reported that the negative effect of cpxA mutation resulted from a decrease in csgA gene transcription from csglin coding.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>Mutations that can result in Diminutive EGL-15 signal can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>Mutations that can result in Loading Signor of the EGL-15 can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>Mutations that can resulted in a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>Mutations that have the ability to result in a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>Mutations that may result in differential splicing may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">differential splicing</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>Mutations that result in the normal splice donor site of intron 12 could not be used can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>Mutations that resulted in a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>Mutations that resulted in loss due to transcriptional repression of the lacZ gene may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">loss due to transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>Mutations that resulted in the net charge of the variant subunit can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>Mutations that resulted in the place of normal splice donor of intron 12 could not be used may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>Mutations that resulting in a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>Mutations that resulting in differential spacing may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">differential spacing</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>The a decrease in transcription of the csgA gene from csglin encoding will result in the the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>The a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>The a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF has resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>The alteration can cause thermal instability and affect Diminutive EGL-15 signal which is shown to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>The alteration can cause thermal instability and affect a decrease in csgA gene transcription from csglin coding that may have resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>The alteration can cause thermal instability and affect a decrease in the transcription of the csgA gene from csglin encoding, which ended up resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>The alteration can cause thermal instability and affect a decrease in transcription of the csgA gene encoding csgA which is able to finally result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor after having resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>The alteration can cause thermal instability and affect mixed alternative subdomains, which can result in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>The alteration can cause thermal instability and affect reduced EGL-15 signaling which has proven to result finally in a phenotype of dirty body morphology .</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>The alteration can cause thermal instability and affect reduced transcription of the csgA gene encoding for the clinic which is observed to result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>The alteration can cause thermal instability and affect reduction of the EGL-15 signaling which is observed to result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>The alteration can cause thermal instability and affect the expression of isoforms of Nrf1, which can result in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit that may have resulted in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>The alteration can result thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling which is capable of giving rise to a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>The alteration can result thermal instability and affect alternative spacer of a single transcription which has finally been shown to be difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor which finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>The alteration may cause thermal instability and affect alternative of a single transcription cut, which may ultimately resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>The alteration may cause thermal instability and affect both the mutations of 5 and 3 splices being demonstrated to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>The alteration may cause thermal instability and affect decreasing EGL-15 signal which may result in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>The alteration may cause thermal instability and affect reduction of csgA gene transcription csgA coding being demonstrated to result in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>The alternative of a single transcription cut, as predicted, has resulted in the difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>The alternative splicing of a single transcription may have resulted in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>The both the mutations at the site of 5 and 3 splices resulted in the of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>The change can cause heat instability and affect Diminutive EGL-15 signal which has been shown to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF by finally being able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>The change can cause heat instability and affect alternative of a single transcription cut which can eventually result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>The change can cause heat instability and affect differential splicing which eventually resulted in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>The change can cause heat instability and affect growth in ras-dependent signaling which will eventually result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>The change can cause heat instability and affect reduction of csgA gene transcription csgA coding which may eventually have resulted in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>The change can cause heat instability and affect the donor place of normal helix of intron 12 could not be used after it has resulted in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>The change can cause heat instability and affect the other three alterations which resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>The change can cause heat instability and affect the other three changes that may have resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>The change can cause thermal instability and affect a decrease in transcription of the csgA gene encoding csgA and is shown to ultimately result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>The decreases the EGL-15 signaling has the ability to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Diminutive EGL-15 signal that was observed to result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF that resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF that may result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both 5 and 3 splice mutations that resulted in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of cDNA isoform II DNA in COS7 resulting in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed failure to use the normal site of the intron 12 splice donor that will result in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed both the mutations of 5 and 3 splices that could resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduced EGL-15 signal results in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF could result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that differential encryption resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that reduced EGL-15 signaling could result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that reduction of csgA gene transcription csgA coding resulted in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor after having resulted a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes both the mutations at the site of 5 and 3 splices after having resulted high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of cDNA isoform II DNA in COS7 after having resulted a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid charge of varying subunits with ability to entirely result in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor that resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes expression of Nrf1 isoforms that resulted in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development that has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes expression of cDNA isoform II DNA in COS7 that resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes reduction of the EGL-15 signaling that resulted in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes the other three alterations that has the ability to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF that resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes reduction of EGL-15 signaling that may have resulted in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>The mixed alternative subdomains resulted in the a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>The some alternative subdomains, as predicted, has the ability to result in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>The the normal site of the intron 12 fitting donor could not be used, as predicted, has the ability to result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>a Clr phenotype has the ability to probably result from a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>a Clr phenotype has the ability to probably result from a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>a decrease in the transcription of the csgA gene encoding csgA has the ability to eventually result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor has the ability to eventually result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor is capable of result rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor, as we have predicted, may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF, as we have predicted, has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling may eventually result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>alternative splicing of a single transcription has resulted in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>alternative splicing of a single transcription is shown to ultimately result in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation cells has the ability to ultimately result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>decreasing EGL-15 signal eventually resulted in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>decreasing EGL-15 signal may have resulted in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>differential encryption may ultimately result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>differential encryption will eventually result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>differential splicing can result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>differential splicing cells can result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>differential splicing may result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>differential splicing, as we have predicted, will result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>exon 13 skipping in animals s1031 may ultimately resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>failure to use the normal site of the intron 12 splice donor may ultimately resulted in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="104">
                    <text>mRNA species with 5 distinct UTRs has the ability to result from alternative exon splicing 139 nt.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="105">
                    <text>mixed alternative subdomains resulted in a superrepetitor .</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="106">
                    <text>multiple alternative subdomains can result in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="107">
                    <text>multiple alternative subdomains cells is eventually able to result in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="108">
                    <text>negative effect of the mutation cpxA has the ability to result from reduced transcription of the csgA curlin encoder gene.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="109">
                    <text>reduced transcription of the csgA gene encoding for the clinic may eventually result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="110">
                    <text>reduced transcription of the csgA gene encoding for the clinic may have finally resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="111">
                    <text>reduced transcription of the csgA gene encoding for the clinic, as we have predicted, is likely to resulting in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="112">
                    <text>reduction of EGL-15 signaling eventually resulted in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="113">
                    <text>reduction of EGL-15 signaling has the ability to eventually result in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="114">
                    <text>reduction of EGL-15 signaling, as we have predicted, is likely to resulting in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="115">
                    <text>some alternative subdomains is likely to resulting in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="116">
                    <text>the net charge of the variant subunit may ultimately result in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="117">
                    <text>the normal splice donor site of intron 12 could not be used eventually resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="118">
                    <text>the normal splice donor site of the 12th intron could not be used, as predicted, may have resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
